T
LLY icon

Tidemark’s Eli Lilly LLY Stock Holding History

Tidemark’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.7K Sell
68
-1
-1% -$1.02K 0.02% 243
2026
Q1 		$63.5K Buy
69
+19
+38% +$19.3K 0.02% 240
2025
Q4 		$53.7K Sell
50
-5
-9% -$4.78K 0.02% 232
2025
Q3 		$42K Buy
55
+4
+8% +$2.98K 0.01% 270
2025
Q2 		$39.8K Buy
51
+21
+70% +$16.3K 0.01% 271
2025
Q1 		$24.8K Sell
30
-25
-45% -$20.8K 0.01% 322
2024
Q4 		$42.5K Buy
55
+5
+10% +$4.14K 0.02% 261
2024
Q3 		$44.3K Hold
50
– – 0.02% 255
2024
Q2 		$45.3K Hold
50
– – 0.02% 231
2024
Q1 		$38.9K Hold
50
– – 0.02% 266
2023
Q4 		$29.1K Buy
+50
New +$29.2K 0.02% 288

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tidemark's LLY Position: Q2 2026 in Review

Tidemark reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $1.02K and leaving 68 shares worth $81.7K. The position accounts for 0.02% of the portfolio, ranked #243.

Tidemark first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tidemark held 68 shares of Eli Lilly worth $81.7K as of Q2 2026.
  • Tidemark sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.02% of Tidemark's portfolio in Q2 2026, its #243 holding.
  • Tidemark first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.